- Same Thing
- Side Effects
- What Is
- Drug Interactions
Are Combivent Respimat and Anoro Ellipta the Same Thing?
Combivent Respimat (ipratropium bromide and albuterol) Inhalation Spray and Anoro Ellipta (umeclidinium and vilanterol) Inhalation Powder are combinations of anticholinergic bronchodilators and selective beta2-adrenergic bronchodilators used to treat chronic obstructive pulmonary disease (COPD).
Side effects of Anoro Ellipta that are different from Combivent Respimat include sinusitis, respiratory tract infection, constipation, diarrhea, pain in extremities, muscle spasms, neck pain, chest pain or discomfort, indigestion, gastroesophageal reflux disease (GERD), abdominal pain, weakness, itching, rash, conjunctivitis, hypersensitivity reactions including anaphylaxis and hives, changes in taste, tremor, and anxiety.
Combivent Respimat may also interact with other bronchodilators, bladder or urinary medicines, heart or blood pressure medications, medications for Parkinson's disease, stimulants, ADHD medications, diet pills, over-the-counter cold or allergy medicine, and medications to treat excess stomach acid, stomach ulcers, motion sickness, or irritable bowel syndrome.
Anoro Ellipta may also interact with monoamine oxidase inhibitors (MAOIs), beta blockers, and other anticholinergic drugs.
What Are Possible Side Effects of Combivent Respimat?
Common side effects of Combivent Respimat include:
- cold symptoms (stuffy nose, sneezing, cough, or sore throat),
- flu-like symptoms,
- difficulty breathing,
- urinary retention and
- fast or irregular heartbeat.
Serious side effects of Combivent Respimat include:
What Are Possible Side Effects of Anoro Ellipta?
Common side effects of Anoro Ellipta include:
- sore throat,
- respiratory tract infection,
- pain in extremities,
- muscle spasms,
- neck pain,
- chest pain or discomfort,
- abdominal pain,
- gastroesophageal reflux disease (GERD),
- irregular heart beats,
- hypersensitivity reactions including anaphylaxis and hives,
- changes in taste,
- tremor, and
What Is Combivent Respimat?
Combivent Respimat (sunitinib malate) is a multi-kinase inhibitor indicated for the treatment of gastrointestinal stromal tumor after disease progression on, or intolerance to imatinib mesylate, for advanced renal cell carcinoma, and for progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable, locally advanced or metastatic disease. Combivent Respimat is available in generic form.
What Is Anoro Ellipta?
Anoro Ellipta (umeclidinium and vilanterol) Inhalation Powder is a combination anticholinergic and long acting beta-adrenoceptor agonist (LABA) used for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
What Drugs Interact With Combivent Respimat?
Combivent Respimat may interact with bladder or urinary medicines, diuretics (water pills), heart or blood pressure medications, medications for Parkinson's disease or depression, other bronchodilators, stimulants, ADHD medications, diet pills, over-the-counter cold or allergy medicine, or medication to treat excess stomach acid, stomach ulcer, motion sickness, or irritable bowel syndrome. Tell your doctor all medications and supplements you use.
What Drugs Interact With Anoro Ellipta?
Anoro Ellipta may interact with monoamine oxidase inhibitors (MAOIs), antidepressants, beta blockers, diuretics, and other anticholinergic drugs. Tell your doctor all medications and supplements you use. During pregnancy, Anoro Ellipta should be used only if prescribed. Tell your doctor if you are pregnant before taking Anoro Ellipta or if you become pregnant during treatment. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
How Should Combivent Respimat be Taken?
The Combivent Respimat inhaler delivers 20 mcg of ipratropium bromide (monohydrate) and 100 mcg albuterol (equivalent to 120 mcg albuterol sulfate) from the mouthpiece. The recommended dose of Combivent Respimat is one inhalation four times a day. Patients may take additional inhalations as required; however, the total number of inhalations should not exceed six within 24 hours.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
GSK. Anoro Ellipta Product Information.